Related Experiment Video

Updated: Aug 10, 2026

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

[Immune parameters in patients with chronic hepatitis C and with various histologic changes]

D M Sobchak, E A Monakova

    Klinicheskaia Meditsina
    |May 29, 2004
    PubMed

    Insights

    In chronic hepatitis C (CHC), higher histological activity and fibrosis correlate with increased pro-inflammatory cytokines (IL-1, IL-2, IL-6, TNF-alpha). Interleukin-4 (IL-4) levels were associated with milder liver disease and higher interferon-alpha.

    Area of Science:

    • Immunology
    • Hepatology
    • Biochemistry

    Context:

    • Chronic hepatitis C (CHC) is a significant global health concern.
    • Understanding the interplay between immune response and liver pathology in CHC is crucial for effective management.
    • Cytokine profiles offer insights into disease activity and progression.

    Purpose:

    • To investigate the correlation between serum cytokine levels and the histological activity index (HAI) and fibrosis in patients with CHC.
    • To identify specific cytokines associated with different degrees of liver inflammation and damage.

    Summary:

    • This study analyzed serum levels of cytokines (IL-1, IL-2, IL-4, IL-6, TNF-alpha) in 22 CHC patients.
    • Higher HAI and severe fibrosis were linked to elevated pro-inflammatory cytokines (IL-1, IL-2, IL-6, TNF-alpha).
    • Interleukin-4 (IL-4) showed an inverse correlation with disease severity, being higher in milder cases and associated with interferon-alpha.

    Impact:

    • The findings highlight the potential of serum cytokines as biomarkers for assessing CHC activity and progression.
    • This research contributes to a deeper understanding of the immune mechanisms driving liver damage in CHC.
    • Results may inform the development of targeted immunomodulatory therapies for CHC.

    More Related Videos

    Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix10:37

    Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

    Published on: October 20, 2021

    Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma08:25

    Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

    Published on: April 25, 2025

    Related Concept Videos

    Hepatitis01:25

    Hepatitis

    Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
    Viral Hepatitis I: Introduction01:28

    Viral Hepatitis I: Introduction

    Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
    Cirrhosis I: Introduction01:23

    Cirrhosis I: Introduction

    Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
    Cirrhosis II: Pathophysiology01:24

    Cirrhosis II: Pathophysiology

    Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...